These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1332365)

  • 21. Immunohistochemical and ultrastructural evidence for the pathogenesis of white matter degeneration in patients with panencephalopathic-type Creutzfeldt-Jakob disease: Inducible nitric oxide synthase overexpression in bizarre astrocytes.
    Kohama H; Kusunoki-Ii M; Kato K; Kato M; Kato S
    Neuropathology; 2020 Aug; 40(4):319-327. PubMed ID: 32236982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuronal degeneration and neurofilament accumulation in the trigeminal ganglia in Creutzfeldt-Jakob disease.
    Guiroy DC; Shankar SK; Gibbs CJ; Messenheimer JA; Das S; Gajdusek DC
    Ann Neurol; 1989 Jan; 25(1):102-6. PubMed ID: 2643917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Divergent effects of hyperosmolality on stress-response (heat shock) protein expression in cultured human tumor cells: an immunocytochemical study.
    Kato M; Herz F; Brijlall D; Kato S
    Experientia; 1994 May; 50(5):479-82. PubMed ID: 8194585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nuclear DNA fragmentation in Creutzfeldt-Jakob disease: does a mere positive in situ nuclear end-labeling indicate apoptosis?
    Ferrer I
    Acta Neuropathol; 1999 Jan; 97(1):5-12. PubMed ID: 9930889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Panencephalopathic type of Creutzfeldt-Jakob disease: primary involvement of the cerebral white matter.
    Mizutani T; Okumura A; Oda M; Shiraki H
    J Neurol Neurosurg Psychiatry; 1981 Feb; 44(2):103-15. PubMed ID: 7012278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental Creutzfeldt-Jakob disease: light microscopic, immunohistochemical and ultrastructural studies of the Fujisaki strain of Creutzfeldt-Jakob disease virus in NIH Swiss mice.
    Liberski PP; Yanagihara R; Gibbs CJ; Gajdusek DC
    Neuropatol Pol; 1991; 29(1-2):1-17. PubMed ID: 1813811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prion protein deposition and abnormal synaptic protein expression in the cerebellum in Creutzfeldt-Jakob disease.
    Ferrer I; Puig B; Blanco R; Martí E
    Neuroscience; 2000; 97(4):715-26. PubMed ID: 10842016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclooxygenase-1 and -2 in brains of patients who died with sporadic Creutzfeldt-Jakob disease.
    Deininger MH; Bekure-Nemariam K; Trautmann K; Morgalla M; Meyermann R; Schluesener HJ
    J Mol Neurosci; 2003 Feb; 20(1):25-30. PubMed ID: 12663931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical study of microglia in the Creutzfeldt-Jakob diseased brain.
    Sasaki A; Hirato J; Nakazato Y
    Acta Neuropathol; 1993; 86(4):337-44. PubMed ID: 8256583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Creutzfeldt-Jakob disease with unusually extensive neuropathology in a child treated with native human growth hormone.
    Mikol J; Deslys JP; Zou WQ; Xiao W; Brown P; Budka H; Goutieres F
    Clin Neuropathol; 2012; 31(3):127-34. PubMed ID: 22551916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of stress proteins alpha B-crystallin, ubiquitin, and hsp27 in pallido-nigral spheroids of aged rhesus monkeys.
    Schultz C; Dick EJ; Cox AB; Hubbard GB; Braak E; Braak H
    Neurobiol Aging; 2001; 22(4):677-82. PubMed ID: 11445268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parvalbumin-immunoreactive cortical neurons in Creutzfeldt-Jakob disease.
    Ferrer I; Casas R; Rivera R
    Ann Neurol; 1993 Dec; 34(6):864-6. PubMed ID: 8250537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression profile of stress proteins, intermediate filaments, and adhesion molecules in experimentally denervated and reinnervated rat facial muscle.
    Tews DS; Goebel HH; Schneider I; Gunkel A; Stennert E; Neiss WF
    Exp Neurol; 1997 Jul; 146(1):125-34. PubMed ID: 9225745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wernicke's encephalopathy with ballooned neurons in the mamillary bodies: an immunohistochemical study.
    Freiesleben W; Söylemezoglu F; Lowe J; Janzer RC; Kleihues P
    Neuropathol Appl Neurobiol; 1997 Feb; 23(1):36-42. PubMed ID: 9061688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropathology of Creutzfeldt-Jakob disease in Japan. With special reference to the panencephalopathic type.
    Mizutani T
    Acta Pathol Jpn; 1981 Nov; 31(6):903-22. PubMed ID: 7032195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Creutzfeldt-Jakob disease with congophilic kuru plaques: CT and pathological findings of the cerebral white matter.
    Kawata A; Suga M; Oda M; Hayashi H; Tanabe H
    J Neurol Neurosurg Psychiatry; 1992 Sep; 55(9):849-51. PubMed ID: 1402981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The nucleus basalis of Meynert in 20 definite cases of Creutzfeldt-Jakob disease.
    Cartier L; Verdugo R; Vergara C; Galvez S
    J Neurol Neurosurg Psychiatry; 1989 Mar; 52(3):304-9. PubMed ID: 2647906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Panencephalopathy of the Creutzfeldt-Jakob disease type].
    Gertz HJ; Stoltenburg G; Cruz-Sanchez F; Lafuente J; Schopol R
    Nervenarzt; 1988 Feb; 59(2):110-2. PubMed ID: 3283576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The spatial patterns of prion protein deposits in Creutzfeldt-Jakob disease: comparison with beta-amyloid deposits in Alzheimer's disease.
    Armstrong RA; Lantos PL; Cairns NJ
    Neurosci Lett; 2001 Jan; 298(1):53-6. PubMed ID: 11154834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunocytochemical and ultrastructural studies of Werdnig-Hoffmann disease.
    Murayama S; Bouldin TW; Suzuki K
    Acta Neuropathol; 1991; 81(4):408-17. PubMed ID: 1851364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.